Singapore markets open in 3 hours 8 minutes

VRTX Jun 2023 320.000 call

OPR - OPR Delayed Price. Currency in USD
Add to watchlist
10.90+1.30 (+13.54%)
As of 03:37PM EDT. Market open.
Full screen
Previous close9.60
Expiry date2023-06-16
Day's range10.21 - 10.90
Contract rangeN/A
Open interest201
  • Zacks

    Halozyme Therapeutics (HALO) Down 34.4% Since Last Earnings Report: Can It Rebound?

    Halozyme Therapeutics (HALO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • Motley Fool

    This Cathie Wood Stock Could Nearly Double, According to Wall Street

    One stock that could ride the market rally is CRISPR Therapeutics (NASDAQ: CRSP). This biotech is seeking to develop breakthrough therapies for difficult-to-treat illnesses using gene editing, and the company's focus in this area earned it a prominent place in the Ark Genomic Revolution ETF, an exchange-traded fund overseen by Cathie Wood. Wood isn't the only one on Wall Street who likes CRISPR.

  • Motley Fool

    This Is My Highest-Conviction Stock to Own in 2023 and Beyond

    While one could say the same about many biotech companies, Vertex has an advantage very few of its peers do: For CF patients, it's the only game in town. Vertex markets the only medicines that target the underlying causes of CF. In 2022, the company's revenue of $8.93 billion jumped by 18% year over year.